e-learning
resources
ERJ
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Global Lung Initiative equations for pulmonary hypertension screening in systemic sclerosis
Thibaud Soumagne, Alicia Guillien, Arnaud Chambellan, Thông Hua-Huy, Anh Tuan Dinh-Xuan, Bruno Degano
Source:
Eur Respir J, 52 (3) 1800528; 10.1183/13993003.00528-2018
Journal Issue:
September
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Thibaud Soumagne, Alicia Guillien, Arnaud Chambellan, Thông Hua-Huy, Anh Tuan Dinh-Xuan, Bruno Degano. Global Lung Initiative equations for pulmonary hypertension screening in systemic sclerosis. Eur Respir J, 52 (3) 1800528; 10.1183/13993003.00528-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Related content which might interest you:
Lung function and pulmonary hypertension in systemic sclerosis
Source: Eur Respir J 2006; 28: Suppl. 50, 548s
Year: 2006
Exercise-induced pulmonary hypertension in patients with systemic sclerosis: Pilot-study
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Global burden of chronic thromboembolic pulmonary hypertension (CTEPH): An epidemiological analysis
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014
Exercise pulmonary hemodynamics in systemic sclerosis patients – Implications for outcome
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016
Long-term data from the Swiss pulmonary hypertension registry
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
The impact of the new Global Lung Function Initiative
T
LCO
reference values on trial inclusion for patients with idiopathic pulmonary fibrosis
Source: Eur Respir J, 53 (2) 1801895; 10.1183/13993003.01895-2018
Year: 2019
Epoprostenol dosing by concomitant therapies in the PROSPECT registry
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Single center experience with systematic diagnostic and predictive genetic screening for pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Pulmonary hemodynamics and lung function in patients with COPD and DPLD
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Lung transplantation in systemic sclerosis: Experience in a spanish center
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014
Global fibrinolytic profile in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015
PAH-specific therapies improve survival in patients with pulmonary arterial hypertension associated with connective tissue diseases: A Russian single centre experience
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Exercise-induced pulmonary pressure changes in scleroderma patients – A follow-up study
Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange
Year: 2014
Minimal skin involvement in systemic sclerosis does not preclude pulmonary involvement – an analysis of the German Network for Systemic Sclerosis (DNSS) Registry
Source: Eur Respir J 2007; 30: Suppl. 51, 66s
Year: 2007
Immune signatures in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Mitomycin-induced pulmonary veno-occlusive disease: Experience from the French pulmonary hypertension network
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Characteristics of patients with pulmonary hypertension in end stage renal disease
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Pulmonary arterial hypertension in Adult-Onset Still’s Disease
Source: Virtual Congress 2021 – All about pulmonary arterial hypertension
Year: 2021
Molecular study of genetic modifiers in patients with pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Specific pulmonary arterial hypertension therapy in COPD patients with severe pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept